GoodRx Holdings Inc. (GDRX) PT Raised to $10 at JPMorgan
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
GoodRx (GDRX) Erupts 40% on Mixed Results but Analysts Praise Better Visibility
August 9, 2022 8:10 AM EDTShares of GoodRx (NASDAQ: GDRX) are up about 40% in premarket trading Tuesday after the company reported decent Q2 results and resolved the dispute between its pharmacy benefit management customers and Kroger.
The telemedicine company reported Q2 adjusted EPS of 6c, down from 8c in the year-ago period, and above the analyst consensus of 4c per share. GDRX reported second-quarter revenue of $191.8 million, up 8.6% YoY and topping the consensus projection of $184.9... More
